NV-001 in the Treatment of Advanced Solid Tumors

Status Not yet recruiting

Clinical Trial Summary

Clinical Trial Description

This study is a single-center, open, dose-escalation Phase I clinical study. It is designed to evaluate the safety, tolerability, preliminary efficacy and immunogenicity of treating NV-001, a king of hybrid-membrane-based tumor vaccine in patients with advanced solid tumors. The patients will be treated with vaccines generated based on their tumor tissues.Various doses will be tested according to the protocol to get preliminary safety and efficacy evidence. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06051760
Study type	Interventional
Source	Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Contact	Dr. Wang
Phone	86(010)87788495
Email	snowflake201@gmail.com
Status	Not yet recruiting
Phase	Phase 1
Start date	December 1, 2023
Completion date	December 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05094804` - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents	Phase 1/Phase 2
Active, not recruiting	`NCT02243592` - Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
Completed	`NCT03445572` - Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With Cancer	N/A
Active, not recruiting	`NCT02860039` - High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant	Phase 2
Completed	`NCT01946217` - Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials	N/A
Completed	`NCT01635413` - Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial)	N/A
Completed	`NCT00026169` - Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure	Phase 1
Recruiting	`NCT04534075` - Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial	Phase 3
Active, not recruiting	`NCT01806129` - Reproductive Health Program in Patients With Cancer	N/A
Recruiting	`NCT03915717` - Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring
Recruiting	`NCT02280161` - Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Recruiting	`NCT05520281` - Short-term Psychodynamic Psychotherapy in Serious Physical Illness	N/A
Terminated	`NCT00532064` - Cardiac Biomarkers in Early Detection of Cardiotoxicity in Patients Receiving Sunitinib or Sorafenib Chemotherapy
Completed	`NCT04990882` - FAPI PET/CT Prospective Interobserver Agreement
Completed	`NCT01896778` - Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer	N/A
Recruiting	`NCT05770102` - DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition	Phase 2/Phase 3
Recruiting	`NCT06090266` - A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents	Phase 1/Phase 2
Recruiting	`NCT05886764` - Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials	N/A
Completed	`NCT01432431` - Spiritual Care in Improving Quality of Life of Patients, Caregivers, and Hospital Staff	N/A
Completed	`NCT01506440` - Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy